We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Breast MRI after Cancer Can Lead to Superfluous Biopsies

By MedImaging International staff writers
Posted on 10 Jun 2019
Print article
Image: A mammography scan (A) compared to breast MRI (B) (Photo courtesy of MedUni).
Image: A mammography scan (A) compared to breast MRI (B) (Photo courtesy of MedUni).
A new study claims that for women with a personal history of breast cancer, surveillance breast MRI results in higher biopsy and cancer detection rates.

Researchers at the Kaiser Permanente Washington Health Research Institute (KPWHRI; Seattle, USA), the University of California Davis (UCD; USA), the University of North Carolina (UNC; Chapel Hill, USA), and other institutions conducted a prospective observational study comparing performance of surveillance mammography and breast MRI. The study included 13,266 women (mean age 60 years) with stage 0–3 breast cancer who underwent 33,938 mammographic and 2,506 breast MRI examinations from 2005 to 2012 in the Breast Cancer Surveillance Consortium.

The women were categorized into two groups: mammography alone (11,745 women) or breast MRI (1,521 women). Performance measures were calculated by using end-of-day assessment and occurrence of second breast cancer events within one year of imaging. The researchers compared performance for breast MRI versus mammography alone, adjusting for women, examination, and primary breast cancer characteristics. Analysis was conducted on a per-examination basis.

The results revealed that breast MRI was associated with younger age at diagnosis, chemotherapy, and higher education and income. For women with a personal history of breast cancer, surveillance breast MRI in resulted in almost double the biopsy rates, and 1.7 times detection rates of second breast cancer events, compared with mammography alone. Breast MRI and mammography also showed the same sensitivity for breast cancer detection and interval cancer rates, indicating that mammography did not miss more cancers that would become clinically detectable during a one-year screening interval. The study was published on June 4, 2019, in Radiology.

“After women complete treatment for breast cancer, guidelines recommend annual mammography to screen for second breast cancers. In practice, breast MRI is also being used to screen a growing number of women who have had breast cancer; but more testing isn't always better,” said lead author Karen Wernli, PhD, of KPWHRI. “Women who had more education and income were also more likely to receive breast MRI; not specifically because they had higher risk of second cancers, but because they likely had more access to resources.”

“Some women may feel reassured when they have a biopsy that shows no cancer, while others want to avoid unnecessary biopsies,” said study co-author Dianne Johnson, who is a breast cancer survivor. “As someone who has had breast cancer and has listened to many other women across the country as part of this study, having to get another biopsy after already being treated for cancer raises women's anxiety and distress until they have the result. But most will endure the stress to be sure about whether the finding is cancer.”

While breast MRI provides a very high sensitivity and negative predictive value, particularly in non-calcified breast lesions, problem-solving definitions are not well defined, and the empirical evidence about specific indications, such as architectural distortions, is sparse.

Related Links:
Kaiser Permanente Washington Health Research Institute
University of California Davis
University of North Carolina


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Ultrasound Needle Guide
Ultra-Pro II

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.